BICYCLIC NITROGENATED HETEROCYCLIC DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

Provided are: a novel compound having a P2X7 receptor inhibitory activity; and a pharmaceutical composition having a P2X7 receptor inhibitory activity. A compound represented by formula (I) (wherein Z1 represents C(R4) or the like; R4 represents a hydrogen atom or the like; Z2 represents C(R5a)(R5a&...

Full description

Saved in:
Bibliographic Details
Main Authors SUGIYAMA SHUICHI, OGAWA TOMOYUKI, KOJIMA EIICHI, KAI HIROYUKI, MASUDA KOJI, YAMADA TORU, KOBAYASHI NAOTAKE
Format Patent
LanguageChinese
English
Published 30.07.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided are: a novel compound having a P2X7 receptor inhibitory activity; and a pharmaceutical composition having a P2X7 receptor inhibitory activity. A compound represented by formula (I) (wherein Z1 represents C(R4) or the like; R4 represents a hydrogen atom or the like; Z2 represents C(R5a)(R5a') or the like; a broken line represents the presence or absence of a bond, wherein, when the brokenline represents the presence of a bond, R5a' is absent; R5a and R5a' independently represent a hydrogen atom or the like; the ring Q represents a substituted or unsubstituted 5-membered non-aromatic heterocyclic ring or the like; Y1 represents O or the like; R2a represents a group represented by the formula -(C(R2a')(R2b'))n-R1; R2b represents a hydrogen atom or the like; R2a' and R2b' independently represent a hydrogen atom or the like; R1 represents a substituted or unsubstituted aromatic carbocyclic group or the like; X represents N(R7a) or the like; R7a represents a hydrogen atom or the like; R3 represents a subst
Bibliography:Application Number: CN201780076470